131 related articles for article (PubMed ID: 23176218)
1. Potential effect of angiotensin II receptor blockade in adipose tissue and bone.
Nakagami H; Osako MK; Morishita R
Curr Pharm Des; 2013; 19(17):3049-53. PubMed ID: 23176218
[TBL] [Abstract][Full Text] [Related]
2. Obesity and gastrointestinal hormones-dual effect of angiotensin II receptor blockade and a partial agonist of PPAR-γ.
Nakagami H; Morishita R
Curr Vasc Pharmacol; 2011 Mar; 9(2):162-6. PubMed ID: 21143167
[TBL] [Abstract][Full Text] [Related]
3. [Hormones and osteoporosis update. Effect of angiotensin II on bone metabolism].
Nakagami H; Morishita R
Clin Calcium; 2009 Jul; 19(7):997-1002. PubMed ID: 19567997
[TBL] [Abstract][Full Text] [Related]
4. Renin angiotensin system inhibition attenuates adipocyte-breast cancer cell interactions.
Rasha F; Ramalingam L; Menikdiwela K; Hernandez A; Moussa H; Gollahon L; Layeequr Rahman R; Moustaid-Moussa N
Exp Cell Res; 2020 Sep; 394(1):112114. PubMed ID: 32504676
[TBL] [Abstract][Full Text] [Related]
5. Angiotensinogen and angiotensin-converting enzyme mRNA decrease and AT1 receptor mRNA and protein increase in epididymal fat tissue accompany age-induced elevation of adiposity and reductions in expression of GLUT4 and peroxisome proliferator-activated receptor (PPARγ).
Krskova K; Filipcik P; Zilka N; Olszanecki R; Korbut R; Gajdosechova L; Zorad S
J Physiol Pharmacol; 2011 Aug; 62(4):403-10. PubMed ID: 22100841
[TBL] [Abstract][Full Text] [Related]
6. Prenatal dexamethasone and postnatal high-fat diet have a synergistic effect of elevating blood pressure through a distinct programming mechanism of systemic and adipose renin-angiotensin systems.
Yu HR; Tain YL; Tiao MM; Chen CC; Sheen JM; Lin IC; Li SW; Tsai CC; Lin YJ; Hsieh KS; Huang LT
Lipids Health Dis; 2018 Mar; 17(1):50. PubMed ID: 29540174
[TBL] [Abstract][Full Text] [Related]
7. Antagonists of the renin-angiotensin system and the prevention of obesity.
Weisinger RS; Begg DP; Jois M
Curr Opin Investig Drugs; 2009 Oct; 10(10):1069-77. PubMed ID: 19777395
[TBL] [Abstract][Full Text] [Related]
8. Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.
Zhang Y; Wang L; Song Y; Zhao X; Wong MS; Zhang W
Osteoporos Int; 2016 Mar; 27(3):1083-1092. PubMed ID: 26439241
[TBL] [Abstract][Full Text] [Related]
9. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
Mori J; Zhang L; Oudit GY; Lopaschuk GD
J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
Yamagishi S; Takeuchi M
Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
[TBL] [Abstract][Full Text] [Related]
11. HIV protease inhibitors activate the adipocyte renin angiotensin system.
Boccara F; Auclair M; Cohen A; Lefèvre C; Prot M; Bastard JP; Capeau J; Caron-Debarle M
Antivir Ther; 2010; 15(3):363-75. PubMed ID: 20516556
[TBL] [Abstract][Full Text] [Related]
12. Systemic and tissue-specific effects of aliskiren on the RAAS and carbohydrate/lipid metabolism in obese patients with hypertension.
Engeli S; May M; Nussberger J; Danser AHJ; Dole WP; Prescott MF; Dahlke M; Stitah S; Pal P; Boschmann M; Jordan J
J Am Soc Hypertens; 2017 Aug; 11(8):488-497. PubMed ID: 28666704
[TBL] [Abstract][Full Text] [Related]
13. [Hypertension, CKD and bone metabolism].
Nakagami H; Morishita R
Clin Calcium; 2011 May; 21(5):685-9. PubMed ID: 21532117
[TBL] [Abstract][Full Text] [Related]
14. [Hypertension and osteoporosis].
Nakagami H; Morishita R
Clin Calcium; 2013 Apr; 23(4):497-503. PubMed ID: 23545739
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
[TBL] [Abstract][Full Text] [Related]
16. The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms.
Kalupahana NS; Moustaid-Moussa N
Crit Rev Biochem Mol Biol; 2012; 47(4):379-90. PubMed ID: 22720713
[TBL] [Abstract][Full Text] [Related]
17. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors.
Janke J; Engeli S; Gorzelniak K; Luft FC; Sharma AM
Diabetes; 2002 Jun; 51(6):1699-707. PubMed ID: 12031955
[TBL] [Abstract][Full Text] [Related]
18. Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?
Ernsberger P; Koletsky RJ
Curr Opin Pharmacol; 2007 Apr; 7(2):140-5. PubMed ID: 17303473
[TBL] [Abstract][Full Text] [Related]
19. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
Babiker F; Al-Jarallah A; Joseph S
PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
